Haloperidol: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Haloperidol. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Parkinsonism | 44.4% |
| Akinesia | 22.2% |
| Akathisia | 13.9% |
| Oculogyric crisis | 5.6% |
| Abdominal pain | 2.8% |
| Tremor | 2.8% |
| Headache | 2.8% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Haloperidol decanoate injection, 50 mg/mL and haloperidol decanoate injection, 100 mg/mL are indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy.
Source: FDA labeling via NIH DailyMed (set 9979e28f…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.